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 We conducted the first systematic review of predictors of emotional distress in people with 
multiple sclerosis (MS) 
 The only reliable predictors of emotional distress were baseline emotional distress and stress-
coping variables 
 Heterogeneity in predictor and outcome variables limits the conclusions that can be drawn  
 For psychological treatment efficacy to advance, a better understanding of the psychological 
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Background: Emotional distress (defined as any negative mood state, including anxiety, 
depression, trauma symptoms and global distress) is common in people with multiple sclerosis 
(PwMS). To develop more integrated care for PwMS requires a better understanding of causal 
variables underlying persistent emotional distress. This systematic review critically appraised and 
synthesised the findings of prospective studies investigating predictors of emotional distress in 
PwMS. Method: CINAHL, Medline, and PsycINFO, were systematically searched for: i) prospective 
cohort studies with ≥1-month follow-up period, which; ii) evaluated baseline clinical and 
demographic, social and/or psychosocial predictors of emotional distress; iii) presented results for 
adults with MS; and iv) used validated measures to assess emotional distress. Risk of bias was 
assessed using an adapted version of the Newcastle-Ottawa Scale. Results: Thirteen studies, reported 
in 17 papers, were included. A wide range of outcome measures and statistical methods were used. 
The most reliable finding was that baseline emotional distress and stress-coping variables predicted 
emotional distress. Less robust support was found for income, negative cognitive illness appraisals 
and poor social support. No other variable often predicted emotional distress. Limitations: Lack of 
consistency across included studies may limit confidence in the results obtained.  Conclusions: Little 
is currently known about how or why some people become and remain distressed following a 
diagnosis of MS, whilst others do not. However, psychological and social factors such as emotional 
distress and stress-coping variables appear to be important. A better understanding of the 
psychological factors underpinning distress in PwMS is needed.  
  




Multiple sclerosis (MS) is a chronic neurodegenerative disease estimated to affect approximately 
2.5 million people worldwide (Dennison, Moss-Morris, & Chalder, 2009; Multiple Sclerosis Trust, 
2020). In MS, multifocal areas of demyelination and axonal loss, believed to be due autoimmune 
aetiology, lead to an accumulation of damage to the central nervous system (Flachenecker, 2006; 
Geurts & Barkhof, 2008). MS presents with a range of motor and sensory impairments, cognitive 
decline, and neurological and neuropsychiatric symptoms (Rosti-Otajarvi & Hamalainen, 2013). The 
combination of resulting disabilities varies from person to person, depending on the location and 
severity of MS lesions. Many people with MS (PwMS) experience episodic symptoms or relapses, 
which only partially resolve, days, weeks, or months following each relapse (Flachenecker, 2006; 
Lublin & Reingold, 1996).  
Emotional distress is more common in PwMS relative to the general population (Feinstein, Roy, 
Lobaugh, Feinstein, & O'Connor, 2004). Emotional distress in PwMS is commonly experienced as 
depression and/or anxiety but can also present as trauma symptoms or more global negative affect 
(Counsell, Hadjistavropoulous, Kehler & Asmundson, 2013). The lifetime prevalance rates for 
depression are 36% to 54% in PwMS compared to 16% in the general US population, with lifetime 
prevalence rates of 36% for anxiety disorders in PwMS versus 29% in the general population (Minden 
et al., 2014). Comparably fewer studies have examined trauma, with point prevalence estimates 
ranging from 5% to 16% for post-traumatic stress syndrome (Chalfant, Bryant & Fulcher, 2004; 
Counsell et al., 2013; Ostacoli et al., 2013). Elevated levels of emotional distress are associated with 
greater disease burden, affecting the quality of life of PwMS (Benito-Leon, Morales, Rivera-Navarro, 
& Mitchell, 2003; Janardhan & Bakshi, 2002). Furthermore, emotional distress is associated with 
greater use of healthcare, increased levels of fatigue and has an adverse impact on social interactions 
(Al-Asmi et al., 2015; Simpson et al., 2019). With at least a third of PwMS experiencing levels of 
anxiety or depression that are high enough to necessitate clinical intervention (Minden, 2014; 
Boeschoten et al., 2017), it is imperative that efficacious psychological interventions are available to 
PwMS. However, few psychological treatment trials for emotional distress in PwMS have been 
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conducted (Dennison & Moss-Morris, 2010; Ires et al., 2019; Sesel, Sharpe, & Naismith, 2018). 
Initial treatment evaluations indicate that cognitive behaviour therapy can reduce symptoms of 
depression when focused on addressing common problems arising in MS (e.g., pain, fatigue, and 
relationship difficulties; Mohr, Boudewyn, Goodkin, Bostrom, & Epstein, 2001). However, the 
magnitude of psychological treatment effects when specifically addressing anxiety and depression are 
limited, with small effect sizes reported in two meta-analyses (Ires et al., 2019; Sesel, Sharpe, & 
Naismith, 2018). The limited efficacy of psychological interventions for emotional distress in PwMS 
is therefore an unmet need requiring practical solutions (McCabe, Ebacioni, Simmons, McDonald, & 
Melton, 2015; Rieckmann, et al., 2018). 
Understanding why some PwMS emotionally adjust to living with the condition, while others 
experience enduring clinical levels of emotional distress, necessitates more prospective research. In 
this way potential causal factors may be elucidated. Presently, empirical work in this area is 
predominantly cross-sectional (Dennison et al., 2009). While cross-sectional studies are essential for 
developing hypotheses regarding potential causal factors and the prevalence of emotional distress in 
PwMS, the findings of such studies are limited due to the problem of reverse causality. A previous 
attempt to synthesise research investigating psychosocial factors involved in the broader concept of 
adjustment, for the large part, reflected the paucity of prospective research (Dennison et al., 2009). 
Another previous review examined the potential role of stress in the progression of MS (Artemidis, 
Anagnostouli, & Alexopoulos, 2011), but none have sought to determine modifiable psychological 
factors which can alleviate emotional distress in PwMS. 
The aim of the present study was to identify factors underlying persistent distress in PwMS, with 
a primary interest in uncovering modifiable psychological processes which could inform the 
development of more effective psychological interventions for emotional distress in PwMS. The 
current review therefore critically appraises and synthesises the findings of prospective studies 
investigating clinical and demographic, social, and psychological predictors of emotional distress in 
PwMS.  




This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). The protocol was 
registered in the PROSPERO database (reg. number CRD42016049031). 
Search Strategy 
MEDLINE, PsycINFO and CINAHL databases were initially searched from January 1960 to 
January 2017. These databases were chosen as they span medical, life sciences, psychological, social 
sciences and allied health literature. Search terms for „multiple sclerosis‟ were combined with terms 
for „distress‟ and „predictor‟ using Boolean operators (see Table 1). Reference lists of included studies 
and previous relevant systematic reviews were hand-searched for additional relevant studies. Searches 
were repeated in January 2020 to identify any new studies of relevance.  
[INSERT TABLE 1 HERE] 
Eligibility Criteria 
Studies were included if they: 1) were peer-reviewed, quantitative, prospective studies which; 2) 
evaluated demographic and clinical, social and/or psychological predictors of emotional distress; 3) 
with at least a one-month follow-up period; 4) used published and validated measures to assess 
emotional distress and; 5) presented results for adults, aged 18 years or over, with MS. No limit was 
placed on the length of time since being diagnosed with MS. Intervention studies and studies 
published in languages other than English were excluded. For the purposes of the review, „emotional 
distress‟ was defined as any negative mood state, including, but not limited to, depression, anxiety, 
trauma symptoms and global distress.  
Screening and Selection  
Following de-duplication, the titles and abstracts of identified studies were screened against the 
inclusion criteria. Studies that did not meet the eligibility criteria were excluded. Full-text copies of 
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potentially relevant papers were obtained and examined for relevance. At both stages, screening was 
performed by PHR/MGC, with a random sample of fifty percent dual screened by a second reviewer 
(JR). Disagreements were resolved through discussion, with the views of the wider review team 
consulted where necessary.  
Data Extraction  
Sample characteristics, distress measures, predictors, statistical methods and results (including r 
values, beta coefficients or odds ratios and/or percentage variance explained) were extracted by 
PHR/CH using a standardised data extraction form and tabulated. Data extraction was cross-checked 
by JR/MGC; disagreements were resolved through discussion. Data from studies reported in multiple 
publications were extracted and reported as a single study with all relevant publications listed. Where 
studies reported multiple analyses, only data from the most complex relevant multivariate analyses 
(i.e. analyses which included the most predictors of emotional distress) were extracted.  
Risk of Bias  
The methodological quality of the studies were independently assessed and cross-checked by 
PHR, MGC and JR using a modified version of the Newcastle-Ottawa Scale for cohort studies (NOS; 
Wells et al., 1999). For the purpose of the review, items relating to control groups were removed, and 
samples were considered representative where the proportion of each clinical course of MS matched 
prevalence estimates (i.e., 80-95% RRMS, 5-15% PPMS; Flachenecker, 2006). In line with guidance 
from the Centre for Reviews and Dissemination (2009), no study was excluded based on the results of 
the risk of bias assessment; rather, risk of bias was considered when interpreting findings.  
Data Synthesis  
Predictors of distress were grouped into three broad categories (clinical and demographic, social, 
and psychological). A narrative rather than a meta-analytic synthesis was undertaken due to 
considerable variability in predictors, outcome measures and analytical methods. This approach was 
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adopted in a prior synthesis of clinical and demographic, social, and psychological predictors of 
distress in cancer patients (Cook et al., 2018). 
3 Results 
The search identified 1,205 papers after removing duplicates, of which 986 were excluded by 
title and the remaining 195 by abstract. Twenty-four papers were screened for inclusion by 
scrutinising the full-text articles. Of these, 15 papers, reporting data from 11 primary studies, met 
eligibility criteria. Two additional studies (Berzins et al., 2017; Cadden, Arnett, Tyry, & Cook, 2018) 
were identified via the updated search, resulting in the inclusion of 17 papers, reporting 13 primary 
studies. Figure 1 outlines the search results and article selection process.  
[INSERT FIGURE 1 HERE] 
Overview of the Included Studies 
Table 2 displays the characteristics of the 13 included studies. Six studies were conducted in 
Australia, three in the USA, and one each in Canada, Sweden, United Kingdom and Serbia. Mean 
sample age ranged from 35.9 to 58.3 years; most participants were female. Mean time since diagnosis 
ranged from 4.7 years to 19.82 years. Ten studies reported the clinical course of MS, of which RRMS 
was the most prevalent, followed by chronic progressive types (i.e., SPMS/PPMS). Level of disease 
severity was reported in 12 studies; most participants had mild or moderate MS. Disease severity was 
determined by self-report measures or by physician reports of the number of symptoms that a person 
was experiencing (see Table 2). 
[INSERT TABLE 2 HERE]  
Self-report measures were primarily used to assess clinical and demographic, social, and 
psychological predictors across the included studies. All emotional distress outcomes were assessed 
using self-report questionnaires (Table 3). Twelve of the 13 studies assessed depression (Aikens et al., 
1997; Berzins et al., 2017; Cadden et al., 2018; Johansson et al., 2016; Kneebone et al., 2015; 
McCabe, 2005; Pakenham, 1999, 2006, 2007; Pakenham & Cox, 2009; Schiaffino et al., 1998; 
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Tepavcevic et al., 2013; Weiland et al., 2018; Simpson et al., 2019; Taylor et al., 2018). Three studies 
assessed anxiety (McCabe, 2005; Pakenham, 2005, 2006, 2007; Pakenham & Cox, 2009), whilst three 
studies assessed global emotional distress (Johansson et al., 2016; Pakenham, 1999, 2005, 2006; 
Pakenham & Fleming, 2011). Only one study (Cadden et al., 2018) used a questionnaire (North 
American Research Committee on Multiple Sclerosis-Depression Scale, NARCOMS-D) designed 
specifically to assess emotional distress in PwMS.  
[INSERT TABLE 3 HERE] 
The duration of follow-up ranged from 3 months to 3 years (Table 2). Four studies collected data 
at three time-points and the remaining studies at two time-points. Attrition rates ranged from 6.59% to 
24% over the total duration of prospective data collection (i.e., baseline to final follow-up; Table 2). 
Eleven studies controlled for significant covariates (e.g., disease variables and demographics) 
identified through preliminary bivariate analyses. Seven studies controlled for baseline levels of 
distress in multivariate analyses.  
Risk of Bias  
Risk of bias is presented in Table 4 for the 13 included studies. Four studies did not adequately 
describe the clinical characteristics of their samples, whilst seven of the remaining nine studies 
recruited samples that appeared adequately reflective of an average community sample of PwMS. 
Seven studies relied on patients self-reporting an MS diagnosis. All studies used either validated 
measures or subscales of validated measures to assess emotional distress. All except two studies 
(Pakenham, 2005, 2006; Schiaffino et al., 1998) reported follow-up periods of six months or greater. 
Most studies (n = 10/12; 83.3%) reported less than 20% attrition over the course of prospective data 
collection. It should be noted that one study did not report the attrition rate. 
 Clinical and Demographic Predictors 
As shown in Table 5, clinical and demographic predictors of emotional distress were examined in 
all studies except one (McCabe, 2005).  
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Age, gender, ethnicity and education level.  
There was limited evidence that age, gender, ethnicity or educational level predicted emotional 
distress. Age only predicted distress in two out of six studies, with younger age predicting more 
severe anxiety (Pakenham, 2006, 2007) and depression (Pakenham, 2006). Of the six studies which 
assessed if gender predicted distress, one study (Berzins et al., 2017) found males had a greater 
probability of being depressed. Ethnicity, assessed in one study, and education level, assessed in three 
studies, did not predict emotional distress.  
Employment status and income. 
Three studies considered employment status as predictors of emotional distress (Cadden et al., 
2018; Johansson et al., 2016; Pakenham & Fleming, 2011), whilst two studies considered income 
(Berzins et al., 2017; Schiaffino et al., 1998). Employment status predicted mood in one study 
(Johansson et al., 2016), whereas income negatively predicted depression in both studies that assessed 
it (Berzins et al., 2017; Schiaffino et al., 1998), indicating that higher income was associated with 
lower levels of depression.  
Relationship status. 
Relationship status was assessed in two studies, reported in three papers, and did not predict 
global emotional distress (Pakenham, 2005; Pakenham & Fleming, 2011), anxiety (Pakenham, 2006) 
or depression (Pakenham, 2006). 
Negative or stressful life events.  
Negative or stressful life events predicted emotional distress in only one of three studies. 
Specifically, self-reported recent negative life changes predicted depression (Kneebone et al., 2015) 
but the number of self-reported negative or stressful life events did not predict either depression 
(Berzins et al., 2017; Pakenham, 1999) or global distress (Pakenham, 1999). 
Religious beliefs.  
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Religious and spiritual beliefs were assessed in one study and did not predict anxiety (Pakenham, 
2007; Pakenham & Cox, 2009) or depression (Pakenham, 2007; Pakenham & Cox, 2009).  
Other demographic predictors. 
One study assessed provision of insurance and found that it did not predict depression (Cadden et 
al., 2018). 
Clinical characteristics. 
There was limited evidence that any of the clinical variables assessed in the included studies 
predicted emotional distress. Physical disability status of MS was evaluated in 10 studies but was 
predictive of depression and anxiety in only three (Aikens et al., 1997; Kneebone et al., 2015; 
Pakenham, 2007). Cognitive functioning was examined in three studies, but did not predict depression 
(Aikens et al., 1997; Johansson et al., 2016), mood (Johansson et al., 2016) or global emotional 
distress (Pakenham & Fleming, 2011). Time since diagnosis or symptom onset was examined in two 
studies, but was not predictive of global emotional distress (Pakenham, 2005), anxiety (Pakenham, 
2006, 2007; Pakenham & Cox, 2009) or depression (Pakenham, 2006, 2007; Pakenham & Cox, 
2009). Poor sleep and fatigue levels were examined in three studies but were predictive of depression 
in only one (Berzins et al., 2017). Neither of the two studies examining MS type/course found it to 
predict either depression (Cadden et al., 2018) or global emotional distress (Pakenham, 2005). 
Single studies examined different additional clinical characteristics. The perceived physical and 
psychological impact of MS on health predicted mood (Johansson et al., 2016), and severity of MS 
symptoms predicted global distress, anxiety and depression (Pakenham, 2005, 2006). Time since 
exacerbation of MS predicted depression (Kneebone et al., 2015). Overall physical health status did 
not predict depression (Tepavcevic et al., 2013), nor did recent relapse (i.e. relapse within the 
preceding six months; Cadden et al., 2018) or disease modifying therapy (Cadden et al., 2018). 
Neither smoking nor degree of physical exercise predicted depression (Cadden et al., 2018). 
Perception of general health status did not predict depression (Pakenham, 1999). 
Social Predictors  
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Three studies broadly considered social and lifestyle predictors of emotional distress (Johansson 
et al., 2016; Pakenham, 1999; Tepavcevic et al., 2013). Of these, two found significant results; higher 
levels of social support and engagement in leisure and lifestyle activities predicted lower levels of 
depression (Pakenham, 1999) whilst lower social activity quality of life predicted greater depression 
(Tepavcevic et al., 2013).  
Psychological Predictors 
Baseline emotional distress. 
Seven of the 13 studies examined whether baseline emotional distress predicted emotional distress 
at follow-up. With the exception of one study, which did not report whether baseline emotional 
distress was predictive of later distress (Cadden et al., 2018), all studies reported significant findings 
(McCabe, 2005; Pakenham, 1999, 2007; Pakenham & Cox, 2009; Pakenham & Fleming, 2011; 
Tepavcevic et al., 2013), with higher levels of emotional distress at baseline predictive of subsequent 
emotional distress.  
Stress and coping.  
Both studies testing stress levels or appraisals found stress to predict emotional distress (Aikens et 
al., 1997; Pakenham, 2005, 2006). Specifically, higher MS-related stress predicted higher levels of 
depression, anxiety and global emotional distress (Pakenham, 2005, 2006), whilst general life stress 
predicted depression (Aikens et al., 1997). Furthermore, five of the six studies that tested the effects 
of coping on distress found coping style to be a significant predictor of emotional distress (Aikens et 
al., 1997; Berzins et al., 2017; Johansson et al., 2016; Pakenham, 1999, 2006). Emotion-focused and 
avoidant coping styles, which broadly refer to a tendency to suppress or avoid unpleasant emotions, 
predicted higher general distress, anxiety and depression (Aikens et al., 1997; Berzins et al., 2017; 
Pakenham, 1999, 2006), whilst acceptance coping styles, in which an individual shows a willingness 
to accept unpleasant internal experiences, predicted lower levels of anxiety and depression 
(Pakenham, 2006). Finally, a weak coping capacity (poor ability to identify internal and external 
resources to overcome a stressor) predicted depression (Johansson et al., 2016).  
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Negative cognitive illness appraisals. 
Negative cognitive illness appraisals predicted emotional distress in two out of three studies 
(Pakenham, 2007; Schiaffino et al., 1998). Appraisals of high illness variability (i.e. the controllability 
and changeability of MS over time) predicted higher levels of depression (Schiaffino et al., 1998), 
whilst sense-making appraisals, such as redefining life purpose (e.g., “I have new life goals because of 
my MS”), predicted lower depression and anxiety (Pakenham, 2007). However, Pakenham (1999) 
found threat, challenge and controllability illness appraisals (i.e. appraising MS as something 
threatening, uncontrollable and which limits opportunities for personal growth) not to predict global 
distress or depression.  
Dispositional hope and benefit-finding.  
The two studies measuring dispositional hope and benefit-finding reported contradictory findings. 
Pakenham (2005) found dispositional hope and benefit-finding did not predict global distress, whilst 
Pakenham and Cox (2009) found benefit-finding in the form of higher lifestyle gains (e.g. learning 
more about healthy lifestyles) predicted lower levels of anxiety and depression.  
Self-efficacy and attributional style. 
The single study that assessed attributional styles (Kneebone et al., 2015) found both global and 
stable attributions predicted depression after separately controlling for the effect of negative recent 
life events and time since exacerbation of MS symptoms. Furthermore, an interaction between a 
history of negative life events and a greater tendency to make global attributions (i.e., adversely 
influences other areas of life) was predictive of higher subsequent depression after controlling for the 
effects of recent negative life events. Self-efficacy was assessed in one study (Berzins et al., 2017) 
and was not directly predictive of depression, although an interaction between self-efficacy and sex 
was.  
Additional psychological variables. 
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Lower self-esteem predicted depression in one study out of two (Berzins et al., 2017; McCabe, 
2005). Increased perceived stigma predicted depression (Cadden et al., 2018), but psychological 
reserve, defined as feelings of belonging, social support and sense of control, did not predict lower 
levels of depression (Cadden et al., 2018).  
Discussion 
This review critically appraised and synthesised prospective research investigating demographic 
and clinical, social, and psychological predictors of emotional distress in PwMS. Thirteen studies, 
reported in 17 papers, were included in the review. Overall, baseline levels of emotional distress and 
stress-coping variables were the most frequently assessed variables and consistently predicted 
subsequent emotional distress. These findings are in keeping with other literature (Cook, Salmon, 
Hayes, Byrne, & Fisher, 2018; Dennison et al., 2009) and indicate that, for many PwMS, emotional 
distress is a persistent problem which may result, in part, from cognitive illness appraisals, coping 
strategies/responses and coping resources (Lazarus & Folkman, 1984; Leventhal et al., 1997; 
Leventhal, Nerenz, & Steel, 1984). This finding lends credence to the importance of routinely 
assessing for emotional distress at an early stage, and offering appropriate intervention, as 
recommended by clinical guidance, to PwMS experiencing emotional distress (National Institute for 
Health and Care Excellence, 2014). 
Poor social support and employment status/income were assessed less frequently. Income 
negatively predicted depression in both studies that considered it as a predictor. Gallo and Matthews 
(2003) argue that low socio-economic environments reduce the capacity of individuals with physical 
health problems to manage stress, thereby increasing vulnerability to negative emotions and 
cognitions. The relationship between socio-economic factors and emotional distress – and the 
potential mediating role of cognitive-emotional factors and social support - is something that would 
benefit from further research. 
There was little evidence that any other demographic, clinical, social or psychological variable 
predicted emotional distress. In particular, disease severity was assessed in 11 studies but only 
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predicted anxiety and depression in three. This is consistent with the findings of a systematic review 
of predictors of emotional distress in cancer (Cook et al., 2018) and supports the notion that emotional 
distress is more closely linked to psychological processes which may influence perception of, or ways 
of coping with, specific clinical difficulties, rather than clinical factors themselves. However, 
although a range of psychological processes were investigated, most were considered in very few 
studies, making it difficult to draw conclusions about their predictive value. Single studies suggest a 
role for stigma, benefit-finding, attributional style, self-esteem and self-efficacy, although confidence 
in these findings is limited. For treatment efficacy to advance, a better understanding of the 
psychological processes which underpin and maintain emotional distress is needed. 
Limitations of the Review 
The review focused exclusively on prospective designs, meaning that only 13 studies were 
included in the final synthesis of evidence. However, we do not see this as a limitation as it highlights 
the need to conduct further prospective studies. Although a comprehensive search strategy was used, 
it is feasible that relevant studies were not included especially given the bias towards publishing 
studies with significant findings. There was considerable variation in the methodology across the 
studies, such as the range and nature of the covariates controlled for, the reliability and validity the 
measures assessing the predictors, the duration of prospective data collection and rates of attrition. 
Furthermore, we chose not to focus the review solely on depression and anxiety, but rather to consider 
emotional distress more broadly, as is reflective of the range of difficulties experienced by PwMS. 
Although this is a strength of the review, the breadth in outcomes and outcome measures limit our 
ability to draw nuanced conclusions about risk factors for specific types of emotional distress.  
Although conclusions drawn from multiple studies can be robust, conclusions about variables 
investigated in a small number of studies cannot be viewed so confidently, particularly given the 
range of outcomes studied. Furthermore, most studies used hierarchical regression to establish 
incremental changes in distress prospectively, whilst controlling for demographic and clinical 
covariates. This approach is vulnerable to higher false positive rates since it does not account for 
measurement error (Westfall & Yarkoni, 2016). Moreover, some studies (for example, Aikens et al., 
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1997) had small sample sizes, which means that some of the inconsistencies observed across studies 
may be actually reflective of lack of power (i.e. Type II errors produce the superficial appearance of 
contradicting studies with larger samples which report positive findings). It will be necessary for 
future prospective studies to use more sophisticated designs with appropriate statistical modelling 
strategies (Cook et al., 2015) to provide greater clarity on clinical, psychological and 
sociodemographic factors involved in the maintenance of emotional distress. 
Conclusion 
The paucity of studies assessing predictors of distress in PwMS means that little is currently 
known about how or why some people become and remain distressed following a diagnosis of MS, 
whilst others do not. However, psychological and social variables such as baseline emotional distress 
and stress-coping variables, and to a lesser extent negative cognitive illness appraisals, poor social 
support and income, appear to be important. There was little evidence that any other demographic, 
clinical, social or psychological variable predicted emotional distress. There are many emerging 
psychological models of distress yet to be tested in propsective designs in PwMS (e.g relational frame 
theory; Hayes, Barnes-Holems, & Roche 2001, or the metacognitive model; Wells & Matthews, 
1996). Overall the results highlight the importance of developing a better comprehension of the 
psychological factors underpinning distress in PwMS and ensure that assessment and interventions for 
emotional distress continues.  
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qualitative synthesis  
(n = 13, reported in 17 
papers) 
Studies assessed for 
eligibility  
(n = 24) 
Studies excluded against inclusion 
criteria (n = 11) 
 
Adults without MS (n = 1) 
No validated measure (n = 3) 
Longitudinal data with > 1 month 
follow-up not reported (n = 5) 
Focus on carers (n = 2) 
 
Studies excluded (n = 1,181) 
 
Excluded by title (n = 986) 
Excluded by abstract (n = 195) 
Studies identified through 
searching Medline, CINAHL Plus 
and PsychINFO 
  
(n = 1,972) 
 
Additional studies identified through other sources 
(n = 11) 
 
Studies after duplicates removed  
(n = 1,205) 
Additional relevant studies identified 
through updated search (n = 2) 
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Table 1: Search Terms Used  
Boolean 
Operator 
Search Terms  Search 
Fields  
 multiple sclerosis OR demyelinating disease OR disseminated sclerosis 
OR encephalomyelitis disseminata 
All fields  
AND emotional distress OR psychological distress OR anxiety OR depress* 
OR posttraumatic stress OR  PTSD OR psychological morbidity OR 
psych*, adjustment OR emotional adjustment OR mood OR 
adjustment disorder OR acute stress disorder OR fear of relapse 
All fields  
AND predict* OR risk factors OR caus* OR vulnerability All fields  
NOT  childhood multiple sclerosis OR adolescent multiple sclerosis OR 
palliative OR paed*carers 
Abstract 
NOT genetic testing OR genetic screening Title  
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Note. ADL = Activities of Daily Living Self-care Scale; AIMS = Physician rated measure of functional health 
status CPMS = Chronic Progressive MS; EDSS = Expanded Disability Status Scale; PDDS = Patient 
Determined Disease Steps; PPMS = Primary Progressive MS; PRMS = Progressive Relapse Remitting MS; 
RRMS = Relapse Remitting MS; SD = Standard Deviation; SPMS = Secondary Progressive MS; T# = Time 
point; 
a 
based on sample of 188;
 b 
analyses conducted on 5369 who completed measures at T1 and T2; 
c
 analyses 
conducted on 199 who completed Beck Depression Inventory at least one time point; 
d
 analyses conducted on 66 
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Table 3. Measurement of dependent variables in included studies 
Dependent 
Variable 




McCabe (2005) MNE: 13.38 (6.04; NR); 
FNE: 11.42 (4.81; NR); 
MWE: 11.97 (4.21; NR); 
FWE: 14.83 (6.89; NR) 
 SCL-90 anxiety 
subscale 
Pakenham (2006) 
Pakenham (2007, 2009) 
5.60 (5.05; 0-24) 
NR 
Depression  BDI Aikens (1997) 
Johansson (2016) 
Pakenham (1999) 
9.1 (7.4; 0-28) 
NR 
6.67 (5.28; NR) 
 CES-D Kneebone (2015) 
Schiaffino (1998) 
22.1 (12.56; 0-59) 
16.19 (11.67; NR) 
 HRSD Tepavcevic (2013) 12.2 (5.4; 3–33) 
 NARCOMS-D Cadden (2018) 1.16 (1.16; NR) 























 POM-SF depression 
subscale  
McCabe (2005) MNE: 16.34 (8.36; NR); 
FNE: 13.68 (6.28; NR); 
MWE: 14.11 (5.60; NR); 
FWE: 17.36 (9.13; NR) 
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 SCL-90 depression 
subscale 
Pakenham (2006) 
Pakenham (2007, 2009) 




DASS-21 Pakenham (2011) NR  
 BSI
a
 Pakenham (1999) 
Pakenham (2005) 
27.34 (22.13; NR) 
13.84 (12.32; NR) 
Mood  BDI – mood subscale  Johanssen (2016) NR  
a
 two somatization items excluded; 
b
 scores collapsed into bands; 
c
 prevalence of „positive screening‟ reported; 
BDI = Beck Depression Inventory; BSI = Brief Symptom Inventory; CES-D = Centre for Epidemiologic Studies 
– Depression scale; DASS-21 = Depression, Anxiety and Stress Scale – 21; FNE = Females with no 
exacerbation of MS; FWE = Females with exacerbation of MS; HRDS = Hamilton Rating Scale for Depression; 
MNE = Males with no exacerbation of MS; MWE = Males with exacerbation of MS; NARCOMS-D = North 
American Research Committee on Multiple clerosis – Depression scale; NR = not reported; PHQ-9 = Patient 
Health Questionnaire – 9; POMS-SF = Profile of Mood States – Short Form; SCL-90 = Symptom Checklist – 90  
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Table 4. Risk of bias using adapted Newcastle-Ottawa Scale  
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Table 5. Summary of study design and significant findings from included papers, grouped by 
dependent variable  
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Notes. Adj. = Adjusted; ADL = Activities of Daily Living Self-care Scale; ADM=Antidepressant Medication; 
AIMS = physician rated measure to assess functional health status; = ;; BDI = Beck Depression Inventory; BFS 
= Benefit Finding Scale; BMI= Body Mass Index; BSI = Brief Symptom Inventory; BSI-18 = Brief Symptom 
Inventory-18; CES-D = Centre for Epidemiologic Studies-Depression Scale; CISS = Coping in Stressful 
Situations Scale; CMSS = Coping with Multiple Sclerosis Scale; DASS =Depression Anxiety and Stress Scale; 
DASS-21=Depression Anxiety Scale-21;  DHQ = Diet History Questionnaire; EDSS = Expanded Disability 
Status Scale; FAI = Frenchay Activities Index; FASQ-R = Functional Assessment Screening Questionnaire – 
Revised; FSS = Fatigue Severity Scale; GLOB = Globality of attributions for negative events; HRSD = 
Hamilton Rating Scale for Depression; HR = Hazard Ratio (scores < 1 are protective factors, scores > 2 are risk 
factors); IMIQ=Implicit Models of Illness Questionnaire;  IPAQ = International Physical Activity 
Questionnaire;  LES = Life Experiences Survey; MASQ = Mood and Anxiety Symptoms Questionnaire; 
MCSDS = Marlowe-Crown Social Desirability Scale; MPAI-C = Mayo-Portland Adaptability Inventory – 
Cognition subscale; MSIS = Multiple Sclerosis Impact Scale; MSIS-P = MSIS-Physical subscale; MSIS-Psy = 
MSIS Psychological subscale; MS = Multiple Sclerosis; MSQoL=Multiple Sclerosis Quality of Life: MSQoL-
MHC= Multiple Sclerosis Quality of Life-Mental Health Component; NARCOMS-D = North American 
Research Committee on Multiple Sclerosis – Depression scale; NR = Not Reported; OR = Odds Ratio; PAIS-SR 
= Psychosocial Adjustment to Illness Scale – Self-Report; PDDS = Patient Determined Disease Steps; P-
MSS=Performance MS Scale;; PHQ-2 = Patient Health Questionnaire – 2; PHQ-9 = Patient Health 
Questionnaire – 9; POMS-SF = Profile of Mood States–Short Form; PR = Prevalence Ratio;QMSE = 
Quantitative Mental Status Exam; RLCQ = Recent Life Changes Questionnaire; RR = Risk Ratio; SCL-90 = 
Symptom Checklist – 90 (a = 6 items from depression and anxiety subscales – does not specify which items, b = 
4 items from depression and anxiety scale – does not specify which); SDMT = Single Digit Modalities Test; 
SHS = Subjective Health Status; SLS = Satisfaction with Life Scale; SMS = Sense Making Scale; SOC = Sense 
of Coherence Scale; SIP-P = Sickness Impact Profile – Physical dimension; SPMS=Secondary Progressive 
Multiple Sclerosis; SRRS = Social Readjustment Rating Scale; SSS = Social Support Scale; STAB = Stability 
of attributions for negative events; TCC = Threat, Challenge, Controllability Scale; TSE; Time since MS 
exacerbation; WCC = Ways of Coping Checklist; WHOQOL-100-SE = World Health Organisation Quality of 
Life-100Self-esteem subscale; WOCQ-R = Ways of Coping Questionnaire – Revised. 
Please note that psychological and social factors were categorised as psychosocial factors and that clinical and 
demographic variables were categorised as non-psychological factors. 
 
 
         
